Zosano Pharma Corporation (NASDAQ:ZSAN) shares rose 10.5% during mid-day trading on Friday . The company traded as high as $0.96 and last traded at $0.93, with a volume of 1,025,679 shares trading hands. The stock had previously closed at $0.84.

Separately, ValuEngine upgraded Zosano Pharma Corporation from a “strong sell” rating to a “sell” rating in a research note on Tuesday, June 6th.

The company’s market capitalization is $36.40 million. The stock’s 50-day moving average price is $1.05 and its 200 day moving average price is $1.54.

Zosano Pharma Corporation (NASDAQ:ZSAN) last announced its earnings results on Thursday, August 10th. The biotechnology company reported ($0.17) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.15) by $0.02. During the same quarter last year, the company earned ($0.54) earnings per share. On average, equities analysts forecast that Zosano Pharma Corporation will post ($0.79) EPS for the current fiscal year.

A number of hedge funds have recently made changes to their positions in the stock. Northern Trust Corp boosted its stake in shares of Zosano Pharma Corporation by 591.4% in the second quarter. Northern Trust Corp now owns 79,234 shares of the biotechnology company’s stock valued at $112,000 after buying an additional 67,774 shares during the period. Granite Point Capital Management L.P. bought a new stake in shares of Zosano Pharma Corporation during the first quarter valued at about $285,000. Victory Capital Management Inc. bought a new stake in shares of Zosano Pharma Corporation during the first quarter valued at about $449,000. Nexthera Capital LP bought a new stake in shares of Zosano Pharma Corporation during the first quarter valued at about $950,000. Finally, Perceptive Advisors LLC bought a new stake in shares of Zosano Pharma Corporation during the first quarter valued at about $950,000. 22.66% of the stock is currently owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION WARNING: “Zosano Pharma Corporation (ZSAN) Stock Price Up 10.5%” was published by Daily Political and is owned by of Daily Political. If you are reading this story on another site, it was illegally copied and republished in violation of U.S. & international trademark and copyright legislation. The correct version of this story can be viewed at https://www.dailypolitical.com/2017/09/03/zosano-pharma-corporation-zsan-stock-price-up-10-5.html.

Zosano Pharma Corporation Company Profile

Zosano Pharma Corporation is a clinical-stage specialty pharmaceutical company. The Company has developed a transdermal microneedle patch system to deliver its formulations of existing drugs through the skin for the treatment of a range of indications. Its microneedle patch system offers consistent drug delivery and improved ease of use and room-temperature stability.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.